1. aBandiera, T.; Lombardi Borgia, A.; Nesi, M.; Perrone, E.; Bossi, R.; Polucci, P.Indazole derivatives as kinase inhibitors for the treatment of cancer. WO/2008/074749 A1, 2008.
2. bFancelli, D. Pulici, M.; Moll, J.; Bandiera, T.Preparation of 1H-furo[3,2-c]pyrazole-5-carboxamide derivative as protein kinase inhibitors. WO/2007/138017, 2007.
3. cBandiera, T.; Lombardi Borgia, A.; Polucci, P.; Villa, M.; Nesi, M.; Angiolini, M.; Varasi, M.Substituted pyrazolo[4,3-c]pyridine derivatives as tyrosine kinase inhibitors, particularly IGF-1R inhibitors, their preparation, pharmaceutical compositions, and use in therapy. WO/2007/068619, 2007.
4. dBandiera, T.; Lombardi Borgia, A.; Orrenius, S. C.; Perrone, E.; Beria, I.; Fancelli, D.; Galvani, A.Substituted pyrrolopyrazole derivatives as tyrosine kinase inhibitors, their preparation, pharmaceutical compositions, and use in therapy. WO/2007/068637, 2007.
5. eFancelli, D.; Moll, J.; Pulici, M.; Quartieri, F.; Bandiera, T.Preparation of 1H-thieno[2,3-c]pyrazoles as kinase, particularly Aurora kinases and IGF-1R inhibitors for treating cancer. WO/2007/009898, 2007.